Abstract
Impact of Molecular Features of Diffuse Large B-Cell Lymphoma on Treatment Outcomes with Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have